Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma.
about
Systemic VHL gene functions and the VHL diseaseHypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic nicheTargeting PD-1/PD-L1 in the treatment of metastatic renal cell carcinomaPaving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the FateMyeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor MicroenvironmentControl of the immune response by pro-angiogenic factorsCirculating biomarkers in advanced renal cell carcinoma: clinical applicationsThe Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer ProgressionSignal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapyMyeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacyMyeloid-derived suppressor cells as regulators of the immune systemThe "two-faced" effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancerCoordinated regulation of myeloid cells by tumoursThe dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.Microenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice.TLR/MyD88-mediated Innate Immunity in Intestinal Graft-versus-Host DiseaseArginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.Targeting immune suppressing myeloid-derived suppressor cells in oncology.Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008.The pre-metastatic niche: finding common ground.Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study.Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasLCpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma.Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation.Eradication of metastatic renal cell carcinoma after adenovirus-encoded TNF-related apoptosis-inducing ligand (TRAIL)/CpG immunotherapyTIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesisMyeloid derived suppressor cells in human diseasesMyeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancerDeregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth.Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape.PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.4-HNE inhibits tube formation and up-regulates chondromodulin-I in human endothelial cells.Myeloid-derived suppressor cells: a novel therapeutic target.Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma.Therapeutic implications of immunogenic cell death in human cancer.Enhancing the efficacy of cancer vaccines in urologic oncology: new directions.Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination?Molecular pathways and targets in cancer-related inflammation.Can inhibition of angiogenesis and stimulation of immune response be combined into a more effective antitumor therapy?
P2860
Q24605882-5BD036FB-AF82-429F-AABA-D31F9199EFA8Q24606366-553C3244-F93D-4864-96F4-34A0AB1F57AAQ26775769-ED155CF8-D084-416A-813C-86D3EEC0CD29Q26777205-06264D75-4D27-4B82-A3B7-BBA2AA55456EQ26799126-F9D2CA76-8E0C-40C1-AAE3-EAA4A8606F60Q27004733-383BDF61-A99F-43EC-91EB-2FBBA808F41BQ27023770-1AEB6780-F4E0-49BE-BE98-EB6B0C835A66Q28076760-E013EE85-6776-4A96-8D97-F31E522CC8B9Q28080262-AB29B0A9-9481-4959-A348-7AF001534216Q28082461-D0E492D7-6D17-4A70-92C0-3449A857D883Q28131637-349F9AC3-E9E7-4AFB-A5FD-8396175DA4BAQ28391375-997570F6-333C-4111-8B25-AE8F103F327EQ28395157-286486EB-0997-4687-9423-12CB8949DB31Q30317628-3E4938D3-2C5C-4B1F-BBD3-F9FE98D7BFF5Q33786788-B290B4E1-E2CE-44C4-AD5C-1EF9E72E617EQ33835099-98E094D2-909F-4F14-B9DF-B9089706EA2BQ33978763-D4A3DF5A-14AD-491D-82E1-DEAA1E8F87CCQ34082067-9FDE3518-8D3C-4AB3-9CCC-40426652D828Q34298754-3EEDF2B6-AA4E-47F4-9D54-D59B4E20880FQ34342357-FDBF8E12-D2A0-4663-B3F6-F10144343408Q34566554-A511902B-15EE-4895-8A80-C7A831274278Q35029951-CB56A229-6CB0-42D9-946A-711F5F696763Q35546240-6DA89F27-C67E-4BAF-A915-E2EB9631420BQ35579455-9B1BDE6F-774D-4862-A140-970D346E77AFQ35721553-996CE72D-1D68-42CE-8A5E-9938661C2F2DQ36108579-2F6052DB-95B2-456E-B5CD-0503B7C26AD8Q36338349-DAF4E1E4-CE0D-41AD-BEBD-B516AC54C48AQ36896764-E32FE4D4-F85D-48E6-80C3-93F40E2DCB16Q36967364-599328B0-8B56-4781-A29B-CAAA00F26114Q36971755-8D86F106-6622-4D7C-ACC2-505730AFEC30Q37066106-9DDC880E-F191-47AA-A651-81DA81424165Q37193568-2AAA72D0-E20C-47A4-8BAD-6A2A03461296Q37376141-7A89E5F4-542C-403B-9AFB-AD250C3E273AQ37393000-71EFA42F-20D6-4879-9943-08391C7F2892Q37409283-A2AE38AE-87D1-4289-9C44-299D12D0263DQ37434072-ED6BE4A6-46C4-4C96-9A89-C40BE9FC5253Q37593466-A48AA4DE-479D-4EB4-9B04-F279360F8881Q37613493-E9D33CE8-AEB0-454F-A523-2FF848B85562Q37729131-A647E244-5847-4DFA-B6B6-2BB475DE9073Q37765493-31AEB0E8-02B4-4B71-8A50-45B1C83F4F35
P2860
Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Oxidative stress regulates exp ...... ssion in renal cell carcinoma.
@en
Oxidative stress regulates exp ...... ssion in renal cell carcinoma.
@nl
type
label
Oxidative stress regulates exp ...... ssion in renal cell carcinoma.
@en
Oxidative stress regulates exp ...... ssion in renal cell carcinoma.
@nl
prefLabel
Oxidative stress regulates exp ...... ssion in renal cell carcinoma.
@en
Oxidative stress regulates exp ...... ssion in renal cell carcinoma.
@nl
P2093
P1476
Oxidative stress regulates exp ...... ession in renal cell carcinoma
@en
P2093
Charles Rosser
Dietmar Siemann
Evgeniy Eruslanov
Hubert Kübler
Johannes Vieweg
Philip Dahm
Sergei Kaliberov
Timothy Tseng
Yoshihisa Sakai
P304
P356
10.4049/JIMMUNOL.181.1.346
P407
P577
2008-07-01T00:00:00Z